Making Drugs Work Better

© 2026 Cellenta Holdings Inc. All Rights Reserved.

Cellenta is developing a metal–organic framework (MOF) drug-delivery platform designed to enhance therapeutic efficacy, stability, and solubility while minimizing adverse effects. Our MOF structures support sustained-release profiles across a broad range of therapeutics. Cellenta’s proprietary, scalable synthesis process is designed to produce high-purity MOFs with a favorable biocompatibility profile and reduced toxicological risk. The manufacturing know-how is owned and controlled by Cellenta.